Search

Your search keyword '"Jorquera, F."' showing total 263 results

Search Constraints

Start Over You searched for: Author "Jorquera, F." Remove constraint Author: "Jorquera, F."
263 results on '"Jorquera, F."'

Search Results

2. Longitudinal outcomes of obeticholic acid therapy in ursodiol‐nonresponsive primary biliary cholangitis: Stratifying the impact of add‐on fibrates in real‐world practice

3. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry

7. Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

9. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry

10. Erratum to: 'Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25)

11. Development and Validation of Hepamet Fibrosis Scoring System-a Simple, Non-invasive Test to Identify Patients With Nonalcoholic Fatty liver Disease With Advanced Fibrosis

12. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (vol 73, pg 17, 2020)

14. Metagenomic and metabolic shift on morbid obese patients undergoing bariatric surgery

15. Clinical Characteristics and Outcome of Drug‐Induced Liver Injury in the Older Patients: From the Young‐Old to the Oldest‐Old

20. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice

22. Papel protector de Arkkemansia spp. frente al desarrollo NAFLD asociado a obesidad en ratones libres de gérmenes trasplantados con microbiota intestinal de donantes tratados con dieta rica en grasa y quercetina

23. Papel protector de Akkermansia SPP frente al desarrollo de NAFLD asociado a obesidad en ratones libres de gérmenes trasplantados con microbiata intestinal de donantes tratados con dieta rica en grasa y quercetina

24. Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study

28. Papel protector de Arkkemansia spp. frente al desarrollo NAFLD asociado a obesidad en ratones libres de gérmenes trasplantados con microbiota intestinal de donantes tratados con dieta rica en grasa y quercetina

29. Papel protector de Akkermansia SPP frente al desarrollo de NAFLD asociado a obesidad en ratones libres de gérmenes trasplantados con microbiata intestinal de donantes tratados con dieta rica en grasa y quercetina

30. Protective Effect of Quercetin Treatment on Gut Microbiota Imbalance in Obesity-Associated NAFLD in Patients and in HFD-FED Mice

31. Intestinal microbiota transplantation to germ-free mice in a in vivo model of nafld associated with a quercetin treatment

32. Metabolic Phenotype Transfer Through Gut Microbiota Transplantation from HFD-Fed and Quercetin Treated Donors Modulates Obesity-Related NAFLD in Germ-Free Mice

33. Intestinal Microbiota Transplantation From HFD-fed and Quercetin Treated Donors Results in a Complex Metabolic Phenotype Transfer that Modulates Obesity-Related NAFLD in Germ Free Mice

34. Papel de la disbiosis intestinal en la patogénesis de la enfermedad de hígado graso no alcohólico (NAFLD) asociada a obesidad en pacientes

35. Protective effect of quercetin treatment on HFD-induced intestinal dysbiosis and barrier dysfunction in an in vivo model of non-alcoholic fatty liver disease

36. Akkermansia spp. mediates protection from obesity-associated NAFLD development in germ free mice following intestinal microbiota transplantation from high fat diet and quercetin treated donors

37. Efecto modulador de la quercetina sobre la disbiosis intestinal en un modelo animal de NAFLD asociada a obesidad

38. Efecto modulador de la quercetina sobre la disbiosis intestinal en un modelo animal de NAFLD asociada a obesidad

39. Papel de la disbiosis intestinal en la patogénesis de la enfermedad de hígado graso no alcohólico (NAFLD) asociada a obesidad en pacientes

40. Metabolic Phenotype Transfer Through Gut Microbiota Transplantation from HFD-Fed and Quercetin Treated Donors Modulates Obesity-Related NAFLD in Germ-Free Mice

41. Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

42. Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection

43. Influence of statines in the modifications of lipid and hydrocarboned metabolism in patients with chronic hepatitis C treated with direct-acting antivirals

45. Long-term evolution of thrombocytopenia in patients with chronic hepatitis C and advanced fibrosis after sustained virological response with direct antiviral agents

46. Akkermansia spp. mediates protection from obesity-associated NAFLD development in germ free mice following intestinal microbiota transplantation from high fat diet and quercetin treated donors

48. Incremental Learning for Large Scale Churn Prediction

49. Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis

Catalog

Books, media, physical & digital resources